Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease  

作　　者：Shahinul Alam Shah Mohammad Fahim 

机构地区：[1]Department of Hepatology,Bangabandhu Sheikh Mujib Medical University,Dhaka 1000,Bangladesh [2]Nutrition and Clinical Services Division,icddr,b,Dhaka 1212,Bangladesh

出　　处：《World Journal of Hepatology》2021年第10期1203-1207,共5页世界肝病学杂志（英文版）（电子版）

摘　　要：Nonalcoholic fatty liver disease(NAFLD)is a global public health concern owing to its substantial contribution to chronic liver diseases.The disease is closely linked to metabolic syndrome(MS),suggesting a common biological pathway and shared disease mechanism for both ailments.Previous studies revealed a close relationship of NAFLD with the components of MS including abdominal obesity,dyslipidemia,hypertension,and hyperglycemia.Hence,a group of experts recently renamed NAFLD as metabolic dysfunction-associated fatty liver disease(MAFLD)in order to encompass a more appropriate pathogenesis of the disease.NAFLD was first named to describe a condition similar to alcoholic hepatitis in absence of significant alcohol consumption.However,knowledge pertaining to the etiopathogenesis of the disease has evolved over the past four decades.Recent evidence endorses NAFLD as a terminology of exclusion and suggests that it may often leads to misdiagnosis or inappropriate management of patients,particularly in clinical practice.On the other hand,the new definition is useful in addressing hepatic steatosis with metabolic dysfunction,which ultimately covers most of the patients with such illness.Therefore,it seems to be helpful in improving clinical diagnosis and managing high-risk patients with fatty liver disease.However,it is imperative to validate the new terminology at the population level to ensure a holistic approach to reduce the global burden of this heterogeneous disease condition.

关 键 词：Nonalcoholic fatty liver disease Metabolic dysfunction-associated fatty liver disease Redefining Redefinition of fatty liver disease 

分 类 号：R575.5[医药卫生—消化系统]